April 03, 2019
The U.S. Securities and Exchange Commission cannot get a quick win in its fraud suit against a company that claimed to have developed biological weapon detection technology, with an Illinois federal judge ruling Tuesday that claims against the company were not dealt with in the criminal trial of its CEO.